BOARD GOVERNANCE • STRATEGIC ADVISORY • INSURANCE & BANKING LEADERSHIP
Certified Independent Director (IICA) & Strategic Leader in Regulated Insurance & Banking.
Aman Pal Singh brings over 25 years of institutional experience to the boardroom. Specializing in governance modernization, cross-border regulatory compliance, and AI-enabled enterprise oversight, Aman provides the strategic foresight necessary for institutions to navigate complex, multi-jurisdictional financial ecosystems.
25+
YEARS OF INSTITUTIONAL GOVERNANCE & OVERSIGHT
IICA
CERTIFIED INDEPENDENT DIRECTOR (IDDB)
Global
CROSS-BORDER REGULATORY EXPERTISE
Executive Positioning
Governance-driven leadership for complex, regulated financial institutions.
Aman Pal Singh operates at the intersection of boardroom governance and executive execution. As a certified Independent Director (IICA), he provides the regulatory oversight and strategic foresight required to drive enterprise resilience, digital transformation, and sustainable growth in regulated global insurance and banking environments.
He enables boards to achieve greater accountability, operational excellence, and AI-forward innovation. His governance philosophy emphasizes that sustainable growth must remain governance-aligned, ensuring that long-term institutional resilience depends on disciplined accountability and transparency.
With foundational leadership experience as MD/CEO of B4E Insurtech Inc. and Benefits for Expats, he leverages deep operational insights to support board-level decision-making, stakeholder alignment, and infrastructure-led modernization.
Aman maintains a selective portfolio of Independent Director and NED mandates, focusing on board-level advisory and committees spanning risk, governance, digital transformation, and cross-border expansion.
Board Committee Alignment
Institutional Expertise
Governance & Risk
Enterprise risk architecture, AI accountability, and multi-jurisdictional regulatory compliance oversight.
Transformation & Scalability
Digital insurance infrastructure, technology-enabled operational redesign, and board-level modernization oversight.
Global Markets
Strategic growth and governance alignment across North America, GCC, and Asian financial ecosystems.
Executive Insights
Strategic perspectives on board governance, insurance modernization, and institutional resilience.
Mis Selling in Insurance
The mis-selling of insurance products within the Middle East and North Africa region represents a significant threat to the long-term viability and reputation of the insurance sector. This issue is not merely a collection of isolated compliance infractions or the actions of a few rogue agents. Instead, it is a systemic governance challenge rooted in the misalignment of distribution incentives, product complexity, and inadequate post-sale verification mechanisms. Boards must recognize that when short-term premium volume is prioritized over product suitability, the resulting conduct risk directly undermines capital preservation and regulatory standing. Many boards misread this issue by treating mis-selling as an operational nuisance or a localized sales force problem that can be managed through standard compliance checklists. This perspective overlooks the structural drivers of mis-selling, such as aggressive commission structures, opaque intermediary relationships, and the lack of clear target market definitions. By failing to look past aggregate sales figures, directors remain blind to the underlying customer dissatisfaction, high lapse rates, and potential regulatory interventions that can abruptly halt business operations. For independent directors and board chairs, the relevance of distribution governance lies in its direct connection to capital allocation and enterprise value. High early-stage lapse rates and policy surrenders represent a direct drain on capital through unrecovered acquisition costs and increased administrative expenses. Furthermore, as regulators across the region intensify their focus on consumer protection and conduct risk, insurers that fail to govern their distribution channels face severe penalties, license suspensions, and irreparable brand damage. The decision pressure facing boards today is immediate and demanding. Directors must shift from a passive, retrospective review of compliance reports to an active, data-driven oversight of all distribution channels. This transition requires the board to demand granular, transaction-level evidence of product suitability, restructure incentive frameworks to align with policyholder retention, and establish clear lines of executive accountability for customer outcomes.
Insurance Distribution Board Analysis
India’s insurance sector is undergoing rapid transformation, driven by regulatory reforms, digital acceleration, and the ongoing challenge of low insurance penetration. The Insurance Regulatory and Development Authority of India (IRDAI) has heightened its focus on distribution conduct, customer outcomes, and board accountability, with clear expectations for insurer boards to provide proactive oversight and substantiated evidence of compliance. While management may present digital and partnership-driven distribution as straightforward growth levers, boards must recognize that these strategies introduce significant risks—including conduct, customer protection, channel conflict, operational resilience, and capital allocation—that are often underestimated at the board level. Distribution is not simply a sales or growth lever; it is a core driver of risk, capital deployment, regulatory credibility, and long-term value. Boards must resist the temptation to view digital adoption and new partnerships as self-correcting growth mechanisms. Instead, they must ensure robust governance, data-driven oversight, and proactive management of conduct, operational, and reputational risks. The board’s responsibility is to challenge management’s assumptions, scrutinize channel economics, and ensure that customer and regulatory outcomes are prioritized over short-term volume gains. The strategic challenge is to balance growth ambitions with the realities of legacy agent networks, evolving customer expectations, and the operational demands of digital transformation. Boards must interrogate whether management’s distribution plans are supported by credible data, effective controls, and a clear understanding of capital and risk implications. Failure to do so risks regulatory censure, reputational damage, suboptimal capital deployment, and erosion of policyholder trust and enterprise value. Boards must demand evidence—not narrative—on the effectiveness, resilience, and compliance of distribution channels. Where management reporting is insufficient, oversight must be escalated. Management must demonstrate, with data, that distribution innovation is delivering sustainable, compliant, and customer-centric growth. Board oversight should be explicit, with clear committee accountability for distribution risk, conduct, and customer outcomes.
Product Innovation Board Analysis
Product innovation in the insurance sector has become a critical boardroom issue, shaped by rapidly evolving policyholder expectations, intensifying regulatory scrutiny, and the emergence of complex risk categories such as cyber, climate, and pandemic exposures. Insurers are piloting embedded insurance, usage-based models, and novel distribution partnerships—including digital MGAs and broker alliances—to capture growth and respond to shifting demand. However, the pace, quality, and governance of these efforts vary widely, exposing insurers to uneven risk, capital, and regulatory profiles. Boards are under mounting pressure to balance growth ambitions and differentiation with robust risk management, capital discipline, and regulatory compliance. Regulatory authorities are sharpening their focus on product governance, customer outcomes, and the processes underpinning innovation. This includes explicit expectations for board oversight, documented risk appetite, and demonstrable alignment with fair customer outcomes. The regulatory lens now extends beyond product outcomes to the governance, controls, and assurance mechanisms supporting innovation. A persistent misjudgment is the assumption that innovation is inherently value-accretive or that digital and embedded offerings will automatically achieve market adoption. In reality, innovation can introduce new risks, operational complexity, and heightened regulatory scrutiny—particularly if product governance, risk assessment, or customer impact analysis is inadequate. Boards must require management to provide clear, evidence-based assurance that product innovation aligns with strategy, is subject to rigorous controls, and is monitored for both commercial and conduct outcomes post-launch. The urgency for boards is clear: regulators are scrutinizing not only the outcomes of product innovation but also the governance processes that underpin them. Decision pressure is intensifying around capital allocation between new products and legacy portfolios, managing the risk of regulatory challenge or consumer harm, and maintaining institutional credibility with investors and supervisors. Boards must insist on clear, evidence-based reporting on product innovation, challenge narrative assertions, and require management to demonstrate that innovation delivers sustainable value without compromising risk, capital, or conduct standards. Explicit board oversight, committee accountability, and management evidence are now non-negotiable for regulatory credibility and sustainable competitive advantage.
Strategic Engagement
Reserved for board governance, institutional advisory, and enterprise leadership.
I currently curate a select portfolio of board and advisory mandates within the global insurance and banking sectors. Inquiries regarding board governance participation or institutional transformation oversight are welcome.